Development of Potential Pharmacological Targets to Normalize GeneExpression in Islets of Type 2 Diabetic Patients
We identified some alterations in the pancreas of patients with T2D, ten hub genes, and five experimental drugs that could potentially correct gene expression abnormalities. However, further studies are required to validate these results.
Authors
- Fernando Martínez–Esquivias (ORCID: https://orcid.org/0000-0002-5059-3153)
- Juan Manuel Guzmán‐Flores (ORCID: https://orcid.org/0000-0002-4673-112X)
- Viridiana Basaldúa-Maciel
Institutions
- Universidad de Guadalajara (MX)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-04-07
- DOI
- https://doi.org/10.2174/0109298673352470250312082922
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00